In recent weeks, some people with Parkinson’s disease have gained access to a new treatment that uses technology to monitor signs of the disease.
The FDA approved the treatment, called adaptive brain stimulation. According to the University of California San Francisco, the treatment uses an implanted device to continually monitor the brain for symptoms of Parkinson’s and then delivers electric pulses to keep those symptoms in check.
It’s one among several recent advancements geared at helping patients. In New York, a new statewide patient registry supports research into finding a cure.
This hour, our guests discuss the latest in Parkinson’s disease research and treatment and how to best support patients and caregivers.
In studio:
- Ruth Schneider, M.D., associate professor on the Department of Neurology, Movement Disorders and the Center for Health and Technology at the University of Rochester Medical Center
- Yvonne Hylton, co-founder, director, and webmistress of the Rochester Parkinson Network
- Kevin Hylton, president and co-founder of the Rochester Parkinson Network, and care partner and husband to Yvonne Hylton
- Amy Jones, local resident living with Parkinson’s, and advocate for the New York State Parkinson’s Disease Registry with Rochester Women vs. Parkinson’s
